Ironwood Pharmaceuticals, Inc. (IRWD)
4.52
-0.09
(-1.95%)
USD |
NASDAQ |
Feb 13, 15:45
Ironwood Pharmaceuticals Cash from Financing (Quarterly) : 0.00 for Sept. 30, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| AbbVie, Inc. | -- |
| Outlook Therapeutics, Inc. | 13.25M |
| Nektar Therapeutics | 141.68M |
| Rigel Pharmaceuticals, Inc. | 4.271M |
| CorMedix, Inc. | 150.53M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 47.58M |
| Cash from Investing (Quarterly) | -0.002M |
| Free Cash Flow | 67.65M |
| Free Cash Flow Per Share (Quarterly) | 0.2677 |
| Free Cash Flow to Equity (Quarterly) | 48.01M |
| Free Cash Flow to Firm (Quarterly) | 52.55M |
| Free Cash Flow Yield | 8.86% |